MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock, net
$823,282K
Proceeds from exercise of
stock options and espp
$135,717K
Net cash provided by
financing activities
$954,073K
Effect of exchange
rates on cash and cash...
$931K
Canceled cashflow
$4,926K
Net (decrease)
increase in cash and cash...
-$44,585K
Canceled cashflow
$955,004K
Change in fair value of
deferred and contingent...
$251,993K
Stock-based compensation
expense
$152,710K
Accounts payable and
accrued liabilities
$100,073K
Royalty financing
non-cash interest...
$20,675K
Depreciation
$10,449K
Non-cash operating lease
expense
$9,652K
Amortization of debt issuance
costs
$6,216K
Amortization of intangible
assets
$6,001K
Finance lease
amortization expense
$2,712K
Maturities of marketable
securities
$2,090,000K
Payments of finance lease
principal
$2,961K
Payments of principal of
0.75 convertible...
$1,965K
Net cash used in
operating activities
-$935,014K
Canceled cashflow
$560,481K
Net cash used in
investing activities
-$64,575K
Canceled cashflow
$2,090,000K
Net loss
-$1,276,775K
Accounts receivable
$88,307K
Prepaid expenses and
other current assets
$53,431K
Accretion of discount on
marketable securities, net
$38,348K
Inventory
$31,519K
Other liabilities
-$4,992K
Other assets
$2,123K
Purchase of marketable
securities
$2,092,014K
Purchase of fixed assets
$32,561K
Payment of az milestone
$30,000K
Back
Back
Cash Flow
source: myfinsight.com
INSMED Inc (INSM)
INSMED Inc (INSM)